Identification of distinct and age-dependent p16<sup>High</sup> microglia subtypes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34598318.
- Also identified by DOI 10.1111/acel.13450 and PMC identifier 8520715.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cells expressing high levels of the cyclin-dependent kinase (CDK)4/6 inhibitor p16 (p16<sup>High</sup> ) accumulate in aging tissues and promote multiple age-related pathologies, including neurodegeneration. Here, we show that the number of p16<sup>High</sup> cells is significantly increased in the central nervous system (CNS) of 2-year-old mice. Bulk RNAseq indicated that genes expressed by p16<sup>High</sup> cells were associated with inflammation and phagocytosis. Single-cell RNAseq of brain cells indicated p16<sup>High</sup> cells were primarily microglia, and their accumulation was confirmed in brains of aged humans. Interestingly, we identified two distinct subpopulations of p16<sup>High</sup> microglia in the mouse brain, with one being age-associated and one present in young animals. Both p16<sup>High</sup> clusters significantly differed from previously described disease-associated microglia and expressed only a partial senescence signature. Taken together, our study provides evidence for the existence of two p16-expressing microglia populations, one accumulating with age and another already present in youth that could positively and negatively contribute to brain homeostasis, function, and disease.
Medical subject headings
- Aging
- Cellular Senescence
- Cyclin-Dependent Kinase Inhibitor p16
- Microglia